A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " SRL,Inc.

SRL,Inc.

Table of Contents
Table of Contents

SRL,Inc.is commissioned by hospitals and clinics across Japan to perform more than 200,000 tests per day. This page provides a general introduction to SRL,Inc.’s Non-Clinical testing characteristics, representative disease models, and case studies to assist sponsor organizations in selecting a Non-Clinical CRO.

Non-Clinical Studies Undertaken by SRL,Inc. (CRO Services)

One-Stop Service

SRL,Inc. maintains an integrated framework that provides consistent support from study preparation through execution, data management, and regulatory submission support. By contracting multiple processes together—such as testing, data management, and data/assay monitoring—SRL,Inc. helps reduce sponsor burden and enables efficient, high-quality study operations. SRL’s extensive portfolio of animal disease models allows selection of models appropriate to a range of indications, supporting both efficacy and toxicology work and contributing to more efficient drug-discovery cycles.

Advanced Analytical Technologies and Broad Testing Capabilities

Using advanced analytical technologies, SRL,Inc. conducts a broad menu of Non-Clinical testing, including pharmacokinetic and toxicology studies. SRL,Inc. performs testing across diverse fields such as biochemistry, endocrinology, oncology, virology, immunology, genetics, and pathology, and implements studies using advanced techniques including real-time PCR, flow cytometry, and pharmacogenomics.

Quality Management Developed Through Contract Clinical Testing

SRL,Inc.’s quality management has been developed through extensive experience in contract clinical testing. The organization operates under a rigorous quality control framework and employs quality-assurance systems aligned with international standards, such as ISO 15189 held by the clinical diagnostics arm, and actively incorporates external evaluations. SRL provides consistent, high-accuracy services from sample receipt and handling (with appropriate chain-of-custody) through data reporting, enabling reliable study operations.

Reference: SRL,Inc. official websitehttps://www.srlmedi.com/basic-research

Introduction to Contracted Companies Managed by SRL,Inc.

NIHON RINSHO

NIHON RINSHO provides high-quality services spanning multiple aspects of healthcare and daily life, centered on contract clinical laboratory testing to address a broad range of testing needs from medical institutions, as well as pharmaceutical analysis and supply sales. Services are delivered through a 24-hour comprehensive laboratory equipped with analytical instruments and supported by a proprietary information system that manages the process end-to-end—from order intake through reporting.

Hoku-shin Clinical Co.

Hoku-shin Clinical provides comprehensive contracted clinical laboratory services and consultation related to clinical testing and laboratory equipment, primarily in Nagano Prefecture. As a partner to regional medical institutions, the company supplies reliable clinical laboratory data through outsourced testing services.

SRL,Inc.'s non-clinical case studies

No case studies are currently listed on the official website.

Corporate Information of SRL,Inc.

SRL,Inc. provides contract clinical laboratory testing services for medical institutions, offering a broad menu that includes advanced genetic testing/analysis, pathology, and cancer gene panel testing. SRL also provides support for hospitals and clinics and clinical research. In addition, the company offers services related to SARS-CoV-2 (COVID-19) testing and genomic medicine.

Address Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, Japan
Tel 03-6279-0900
Website https://www.srl-group.co.jp/
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services